rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2005-4-4
|
pubmed:abstractText |
The major aims of the study were to compare the safety of a continuous low-dose estradiol-releasing vaginal ring (ESTring) to that of a vaginal estradiol tablet (Vagifem) on the endometrium and the relief of subjective symptoms and signs of urogenital estrogen deficiency. Quality of life and acceptability of treatment delivery were also assessed.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1369-7137
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
83-92
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15804736-Administration, Intravaginal,
pubmed-meshheading:15804736-Aged,
pubmed-meshheading:15804736-Aged, 80 and over,
pubmed-meshheading:15804736-Analysis of Variance,
pubmed-meshheading:15804736-Endometrium,
pubmed-meshheading:15804736-Estradiol,
pubmed-meshheading:15804736-Estrogens,
pubmed-meshheading:15804736-Female,
pubmed-meshheading:15804736-Female Urogenital Diseases,
pubmed-meshheading:15804736-Follow-Up Studies,
pubmed-meshheading:15804736-Humans,
pubmed-meshheading:15804736-Middle Aged,
pubmed-meshheading:15804736-Patient Satisfaction,
pubmed-meshheading:15804736-Prospective Studies,
pubmed-meshheading:15804736-Quality of Life,
pubmed-meshheading:15804736-Treatment Outcome,
pubmed-meshheading:15804736-Vagina
|
pubmed:year |
2005
|
pubmed:articleTitle |
Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.
|
pubmed:affiliation |
Research Division of FPA Health, Sydney Centre for Reproductive Health Research, Ashfield, NSW, Australia.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|